Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...

The pivotal leap in genome technology that helped lead to the $1,000 genome was in 2014, when improvements were made across the sequencing chain. Enhancements in the chemistry, imaging ...

Genome sequencing is more affordable than ever; in fact, we are nearing the benchmark of a "$1,000 genome" (Wolinsky, 2007).

One in every 10 people worldwide is impacted by a rare genetic disease but about 50% of them remain undiagnosed despite rapid increases in genetic technology and testing.